4519.T+3.60%23.6%
ALNY-48.01%23.6%
ARWR+308.39%23.6%
WVE-47.88%23.6%
2257.HK-63.23%4.7%
NVO-17.97%1.0%
As of Aug 24, 2026, 4:53 AM ET
GLP-1 Long '26: RNA Fat Redistribution Constituents
Alnylam Pharmaceuticals, Inc.ALNY | 23.6% | 3.02% | 6.79% | -13.08% | 14.94% | -40.60% | -29.05% | -11.47% | -13.36% | 19.06% | -48.01% | $31.61B |
Arrowhead Pharmaceuticals, Inc.ARWR | 23.6% | -0.41% | -2.39% | 1.76% | 2.91% | 31.21% | 37.68% | 586.45% | 251.53% | 40.16% | 308.39% | $12.27B |
Chugai Pharmaceutical Co., Ltd.4519.T | 23.6% | -1.27% | -1.42% | -2.36% | -0.44% | -16.27% | -33.99% | -1.36% | -11.34% | 12.88% | 3.60% | $72.69B |
Wave Life Sciences Ltd.WVE | 23.6% | 0.76% | 4.75% | -8.95% | -3.99% | -68.88% | -62.02% | -30.12% | -7.84% | -12.13% | -47.88% | $1.04B |
Sirnaomics Ltd.2257.HK | 4.7% | -0.90% | -3.25% | -3.37% | -2.40% | -50.00% | -44.60% | 11.16% | 50.74% | -95.07% | -63.23% | $53.7M |
Novo Nordisk A/SNVO | 1.0% | 1.30% | -0.91% | -4.16% | -0.72% | -8.14% | 24.81% | -31.51% | -65.88% | -8.31% | -17.97% | $207.55B |
| Theme return | — | 0.47% | 1.66% | -1.17% | 3.15% | -26.61% | -23.84% | 55.65% | 45.90% | 67.83% | 4.54% | — |
| Average | 16.7% | 0.42% | 0.60% | -5.03% | 1.72% | -25.45% | -17.86% | 87.19% | 33.98% | -7.23% | 22.48% | $54.20B |
| Median | 23.6% | 0.18% | -1.16% | -3.76% | -0.58% | -28.43% | -31.52% | -6.41% | -9.59% | 2.28% | -32.92% | $21.94B |
| Std Dev | 9.8% | 1.47% | 3.78% | 4.78% | 6.28% | 32.44% | 36.41% | 223.78% | 102.98% | 42.98% | 129.75% | $72.90B |
| Min | 1.0% | -1.27% | -3.25% | -13.08% | -3.99% | -68.88% | -62.02% | -31.51% | -65.88% | -95.07% | -63.23% | $53.7M |
| Max | 23.6% | 3.02% | 6.79% | 1.76% | 14.94% | 31.21% | 37.68% | 586.45% | 251.53% | 40.16% | 308.39% | $207.55B |
| % Positive Tickers | 50.00% | 33.33% | 16.67% | 33.33% | 16.67% | 33.33% | 33.33% | 33.33% | 50.00% | 33.33% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
GLP-1 Long '26: RNA Fat Redistribution tracks 6 publicly listed stocks in this theme: 4519.T, ALNY, ARWR, WVE, 2257.HK, NVO. See the constituent table for details.